Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

MyNCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1953 2
1954 5
1955 4
1958 2
1960 3
1961 3
1965 7
1966 21
1967 28
1968 30
1969 39
1970 51
1971 47
1972 69
1973 50
1974 75
1975 79
1976 61
1977 88
1978 66
1979 48
1980 53
1981 62
1982 74
1983 117
1984 133
1985 154
1986 173
1987 167
1988 211
1989 309
1990 285
1991 256
1992 317
1993 349
1994 359
1995 355
1996 371
1997 356
1998 460
1999 455
2000 505
2001 676
2002 723
2003 705
2004 800
2005 966
2006 931
2007 1082
2008 1279
2009 1347
2010 1523
2011 1704
2012 1900
2013 2095
2014 2318
2015 2340
2016 2192
2017 2288
2018 2252
2019 1405
2020 53
Text availability
Article attribute
Article type
Publication date

Search Results

31,875 results
Results by year
Filters applied: . Clear all
Page 1
Hepatocellular carcinoma: From diagnosis to treatment.
Grandhi MS, Kim AK, Ronnekleiv-Kelly SM, Kamel IR, Ghasebeh MA, Pawlik TM. Grandhi MS, et al. Surg Oncol. 2016 Jun;25(2):74-85. doi: 10.1016/j.suronc.2016.03.002. Epub 2016 Mar 5. Surg Oncol. 2016. PMID: 27312032 Review.
AASLD guidelines for the treatment of hepatocellular carcinoma.
Heimbach JK, Kulik LM, Finn RS, Sirlin CB, Abecassis MM, Roberts LR, Zhu AX, Murad MH, Marrero JA. Heimbach JK, et al. Hepatology. 2018 Jan;67(1):358-380. doi: 10.1002/hep.29086. Hepatology. 2018. PMID: 28130846 No abstract available.
Radiotherapy for Hepatocellular Carcinoma: New Indications and Directions for Future Study.
Ohri N, Dawson LA, Krishnan S, Seong J, Cheng JC, Sarin SK, Kinkhabwala M, Ahmed MM, Vikram B, Coleman CN, Guha C. Ohri N, et al. J Natl Cancer Inst. 2016 Jul 4;108(9):djw133. doi: 10.1093/jnci/djw133. Print 2016 Sep. J Natl Cancer Inst. 2016. PMID: 27377923 Free PMC article. Review.
Management consensus guideline for hepatocellular carcinoma: 2016 updated by the Taiwan Liver Cancer Association and the Gastroenterological Society of Taiwan.
Surveillance group; Diagnosis group; Staging group; Surgery group; Local ablation group; TACE/TARE/HAI group; Target therapy/systemic therapy group; Radiotherapy group; Prevention group; Drafting group. Surveillance group, et al. J Formos Med Assoc. 2018 May;117(5):381-403. doi: 10.1016/j.jfma.2017.09.007. Epub 2017 Oct 24. J Formos Med Assoc. 2018. PMID: 29074347 Free article.
Innovations in the Management of Hepatocellular Carcinoma.
Rafiullah, Ali A, Mohiuddin H, Zahid U, Abushahin L. Rafiullah, et al. Am J Ther. 2018 May/Jun;25(3):e362-e368. doi: 10.1097/MJT.0000000000000713. Am J Ther. 2018. PMID: 29561268 No abstract available.
Transarterial Therapies for Hepatocellular Carcinoma.
Makramalla A, Itri JN, Choe KA, Ristagno RL. Makramalla A, et al. Semin Roentgenol. 2016 Apr;51(2):95-105. doi: 10.1053/j.ro.2016.02.005. Epub 2016 Feb 5. Semin Roentgenol. 2016. PMID: 27105964 Review. No abstract available.
31,875 results
Jump to page
Feedback